LOQTEQ®
Comparative study of aap osteotomy implant's fatigue strength reveals outstanding characteristics compared with market leader - Seite 2
[3] Petersen, W. et al. (2014) Stability of two angular stable locking plates for open wedge high tibial osteotomy (HTO): TomoFix(TM) versus LOQTEQ® HTO plate, Archives of Orthopaedic and Trauma Surgery
_____________
aap Implantate AG (ISIN DE0005066609) - Prime Standard/Regulated Market - All German stock markets -
About aap Implantate AG
aap is a global medical device company headquartered in Berlin, Germany that develops, manufactures and markets innovative biomaterials and implants that are used in
orthopedic procedures. The Company's products, which include a full line of plating systems, cannulated screws and bone cement products, are primarily used in the orthopedic specialty areas of
trauma and spine repair. The Company's products are sold through its direct sales force, distribution partners and license agreements with OEM partners. aap's stock is
listed in the Prime Standard segment of the Frankfurt Stock Exchange. For more information, please visit www.aap.de, or download the Company's investor relations app from the Apple's App Store or
Google Play.
Forward-looking statement
This release may contain forward-looking statements based on current experience, estimates and projections of the management board and currently available information. They are not guarantees of
future performance. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or
performance of the company and the estimates given here. Many factors could cause the actual results, performance or achievements of aap to be materially different from those that may be
expressed or implied by such statements. These factors include those discussed in aap's public reports. Forward-looking statements therefore speak only as of the date they
are made. aap does not assume any obligation to update the forward-looking statements contained in this release or to conform them to future events or developments.